Pin1 plays a key role in the response to treatment and clinical outcome in triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) is the subset of breast cancer associated with the poorest outcome, and currently lacks targeted treatments. Standard of care (SoC) chemotherapy often consists of DNA damaging chemotherapies ± taxanes, with a range of responses observed. However, we c...

Descripción completa

Detalles Bibliográficos
Autores principales: Knowlson, Catherine, Haddock, Paula, Bingham, Victoria, McQuaid, Stephen, Mullan, Paul B., Buckley, Niamh E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
TNBC in 2019: promising signals for the treatment of a formidable disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065279/
https://www.ncbi.nlm.nih.gov/pubmed/32215056
http://dx.doi.org/10.1177/1758835920906047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065279/
https://www.ncbi.nlm.nih.gov/pubmed/32215056
http://dx.doi.org/10.1177/1758835920906047

Ejemplares similares